questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Sarcoïdose
Sarcoïdose pulmonaire
Sarcoïdose pulmonaire : Questions médicales fréquentes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire : Questions médicales les plus fréquentes",
"headline": "Sarcoïdose pulmonaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sarcoïdose pulmonaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-28",
"dateModified": "2025-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert P Baughman",
"url": "https://questionsmedicales.fr/author/Robert%20P%20Baughman",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio."
}
},
{
"@type": "Person",
"name": "Dominique Valeyre",
"url": "https://questionsmedicales.fr/author/Dominique%20Valeyre",
"affiliation": {
"@type": "Organization",
"name": "Service de Pneumologie, INSERM UMR 1272, Université Sorbonne Paris Nord, AP-HP Hopital Avicenne, Bobigny, France."
}
},
{
"@type": "Person",
"name": "Jan C Grutters",
"url": "https://questionsmedicales.fr/author/Jan%20C%20Grutters",
"affiliation": {
"@type": "Organization",
"name": "Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands."
}
},
{
"@type": "Person",
"name": "Rohit Gupta",
"url": "https://questionsmedicales.fr/author/Rohit%20Gupta",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hilario Nunes",
"url": "https://questionsmedicales.fr/author/Hilario%20Nunes",
"affiliation": {
"@type": "Organization",
"name": "AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, 93009, France; INSERM UMR 1272, Sorbonne Paris-Nord University, Bobigny, 93009, France. Electronic address: hilario.nunes@aphp.fr."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "T-cell signature cytokines distinguish pulmonary sarcoidosis from pulmonary tuberculosis.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37505436",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/eji.202250255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Value of Imaging and Serological Biomarkers in Pulmonary Sarcoidosis.",
"datePublished": "2024-04-28",
"url": "https://questionsmedicales.fr/article/38804438",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/arm92030020"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35752806",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12931-022-02094-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "How Informed Are German Patients with Pulmonary Sarcoidosis about Their Disease?",
"datePublished": "2023-04-13",
"url": "https://questionsmedicales.fr/article/37054695",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000529890"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Artificial Intelligence Platform for the Radiologic Diagnosis of Pulmonary Sarcoidosis: An Initial Pilot Study of Chest Computed Tomography Analysis to Distinguish Pulmonary Sarcoidosis from a Negative Lung Cancer Screening Scan.",
"datePublished": "2023-11-14",
"url": "https://questionsmedicales.fr/article/37962584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00408-023-00655-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sarcoïdose",
"item": "https://questionsmedicales.fr/mesh/D012507"
},
{
"@type": "ListItem",
"position": 6,
"name": "Sarcoïdose pulmonaire",
"item": "https://questionsmedicales.fr/mesh/D017565"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sarcoïdose pulmonaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sarcoïdose pulmonaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-28",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sarcoïdose pulmonaire",
"description": "Comment diagnostiquer la sarcoïdose pulmonaire ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles ?\nQuelles sont les caractéristiques radiologiques ?\nLa biopsie est-elle toujours nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sarcoïdose pulmonaire",
"description": "Quels sont les symptômes courants ?\nLa fatigue est-elle un symptôme ?\nY a-t-il des symptômes systémiques ?\nLes symptômes varient-ils d'un patient à l'autre ?\nLes symptômes peuvent-ils s'aggraver ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sarcoïdose pulmonaire",
"description": "Peut-on prévenir la sarcoïdose pulmonaire ?\nY a-t-il des facteurs environnementaux à éviter ?\nLe tabagisme influence-t-il la sarcoïdose ?\nDes vaccinations sont-elles recommandées ?\nLe stress a-t-il un impact sur la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sarcoïdose pulmonaire",
"description": "Quels traitements sont disponibles ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils toujours nécessaires ?\nComment surveiller l'efficacité du traitement ?\nLes effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sarcoïdose pulmonaire",
"description": "Quelles sont les complications possibles ?\nLa sarcoïdose peut-elle affecter d'autres organes ?\nComment prévenir les complications ?\nLes complications sont-elles réversibles ?\nQuels sont les signes d'alerte des complications ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sarcoïdose pulmonaire",
"description": "Quels sont les facteurs de risque connus ?\nL'exposition professionnelle est-elle un facteur ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe sexe influence-t-il le risque ?\nL'âge est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017565?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la sarcoïdose pulmonaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, radiologiques et histologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la radiographie thoracique, la tomodensitométrie et la biopsie."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent aider à évaluer l'inflammation et la fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Quelles sont les caractéristiques radiologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe souvent des adénopathies hilaires et des infiltrats pulmonaires."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle toujours nécessaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais elle est souvent essentielle pour confirmer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la toux, l'essoufflement et la douleur thoracique."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue est fréquente et peut être sévère chez les patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fièvre et la perte de poids peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent s'aggraver avec le temps ou lors de poussées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la sarcoïdose pulmonaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention connue pour la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des agents irritants ou allergènes peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la sarcoïdose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les symptômes et la progression de la maladie."
}
},
{
"@type": "Question",
"name": "Des vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune vaccination spécifique n'est recommandée pour prévenir la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la maladie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut exacerber les symptômes, mais il ne cause pas la sarcoïdose."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes sont le traitement principal pour réduire l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des immunosuppresseurs peuvent être utilisés si les corticostéroïdes sont inefficaces."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils toujours nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains patients peuvent ne pas nécessiter de traitement actif."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance se fait par des examens cliniques et des tests de fonction pulmonaire."
}
},
{
"@type": "Question",
"name": "Les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent causer des effets secondaires comme la prise de poids."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pulmonaire et l'insuffisance respiratoire."
}
},
{
"@type": "Question",
"name": "La sarcoïdose peut-elle affecter d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut toucher les yeux, la peau, et le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme une aggravation de l'essoufflement ou de la douleur thoracique doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin et l'origine ethnique afro-américaine."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle est-elle un facteur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines professions exposent à des agents susceptibles de déclencher la maladie."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de sarcoïdose peut augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer la sarcoïdose que les hommes."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la sarcoïdose est plus fréquente chez les adultes jeunes et d'âge moyen."
}
}
]
}
]
}
Sarcoidosis is a systemic inflammatory disorder characterized by tissue infiltration due to mononuclear phagocytes and lymphocytes and associated noncaseating granuloma formation. Pulmonary sarcoidosi...
Sarcoidosis is a multisystem granulomatous disease of an unknown aetiology. It can exist in many organs. Pulmonary and intrathoracic lymph nodes are most commonly involved. Lung sarcoidosis is uncommo...
Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases...
Patients with sarcoidosis and a DLCO < 50% predicted were included in this retrospective cohort study. First measurement of DLCO < 50% predicted was the baseline. Lung function data, HRCT, pulmonary h...
106 patients with a DLCO < 50% predicted were included. Evolution of forced vital capacity (FVC) varied widely between patients from - 34% to + 45% after 2 years follow-up, whereas change in DLCO vari...
In conclusion, within this group with advanced pulmonary sarcoidosis disease course varied widely from great functional improvement to death. PF-ILD patients had higher mortality rate than the mortali...
Sarcoidosis is a multisystemic disease with a heterogenous course of disease. Comprehensive information about the complexity and treatment indications is essential for improving patient knowledge and ...
The aim of our study was to investigate the level and resources of information in patients with sarcoidosis and to analyze differences in patient subgroups including age and gender....
We conducted a questionnaire-based online survey in Germany and three semi-structured focus group interviews. The interviews were evaluated independently by two investigators using a structured qualit...
A total of 402 completed questionnaires were analyzed, 65.8% of participants were women, and the mean age was 53 years. The majority of patients felt well informed about their disease in general (59.4...
A relevant proportion of patients with sarcoidosis are inadequately informed about their own disease, particularly with regard to factors impeding quality of life such as fatigue. Efforts are needed t...
To determine the reliability of an artificial intelligence, deep learning (AI/DL)-based method of chest computer tomography (CT) scan analysis to distinguish pulmonary sarcoidosis from negative lung c...
Chest CT scans of pulmonary sarcoidosis were evaluated by a clinician experienced with sarcoidosis and a chest radiologist for clinical and radiologic evidence of sarcoidosis and exclusion of alternat...
The sensitivity, specificity, positive and negative predictive value of the AI/DL method for the 5 folds of the training/validation sets and the entire set of CT scans were all over 94% to distinguish...
This AL/DL model shows promise to distinguish sarcoidosis from alternative pulmonary conditions using minimal radiologic data....
Sarcoidosis (SA) is a granulomatous disorder, which mostly affects the lungs. Its clinical characteristics resemble tuberculosis (TB), but its treatment is different. The etiology of SA is unknown; ho...
Although the imaging manifestations of pulmonary sarcoidosis have been described in detail in previous studies, a consensus has not been reached on the imaging presentation of non-specific interstitia...
A 53-year-old male presented to the hospital with a five-year history of recurrent coughing up sputum and a four-year history of shortness of breath. In addition to the typical features of pulmonary s...
This suggests that NSIP may act as a rare comorbidity of pulmonary sarcoidosis thereby resulting in the patient's HRCT presenting differently from routine sarcoidosis imaging....
Immune checkpoint inhibitor (ICI) therapy has reshaped the treatment landscape in many cancers including non-small cell lung cancer (NSCLC). ICI-therapy can lead to a diverse array of immune-related a...
This is the first case to provide significant evidence that JAK inhibitor is an effective treatment for both subcutaneous and pulmonary sarcoidosis, and it is also the first case in which tofacitinib ...
Sarcoidosis is the most common granulomatous disease in northern Europe. A distinction is made between acute forms of sarcoidosis and chronic sarcoidosis. Chronic sarcoidosis can affect practically al...